|
Quest for blockbuster obesity drug vexes firms (1112 words) |
 | Taking the drug could carry with it the risk of side effects such as insomnia, rapid heartbeat and elevated blood pressure, according to data from clinical trials sponsored by BASF Pharma, the company's pharmaceuticals arm. |
| Before drugs like Xenical and Meridia can reach their potential, companies say, the possibility of a pharmaceutical treatment for obesity would have to be more widely accepted. |
| He said drugs on the market are not very effective "weight-reducing agents, and for most people only have small effect." Some anti-obesity treatments have proved not only hard to stick to but potentially dangerous. |
Feeds |
Contact